Bosentan and sildenafil: Should the combination therapy be a valid alternative in childhood to prostacyclin infusion?

Gianluca Brancaccio, Alessandra Toscano, Maurizio Bevilacqua, Luca Di Chiara, Francesco Parisi

Research output: Contribution to journalArticle

Abstract

We report a case of a seven-yr-old girl with a PAH treated with continuation therapy of bosentan and sildenafil. The combination therapy revealed safety and efficacy in long-term follow up.

Original languageEnglish
Pages (from-to)110-112
Number of pages3
JournalPediatric Transplantation
Volume11
Issue number1
DOIs
Publication statusPublished - Feb 2007

Keywords

  • Bosentan
  • Pulmonary arterial hypertension
  • Sildenafil

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Fingerprint Dive into the research topics of 'Bosentan and sildenafil: Should the combination therapy be a valid alternative in childhood to prostacyclin infusion?'. Together they form a unique fingerprint.

  • Cite this